Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study.
Determination of the optimal dose of renal replacement therapy in critically ill patients with acute kidney injury has been controversial. Questions have recently been raised regarding the design and execution of the US Department of Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network (ATN) Study, which demonstrated no improvement in 60-day all-cause mortality with more intensive management of renal replacement therapy. In the present article we present our rationale for these aspects of the design and conduct of the study, including our use of both intermittent and continuous modalities of renal support, our approach to initiation of study therapy and the volume management during study therapy. In addition, the article presents data on hypotension during therapy and recovery of kidney function in the perspective of other studies of renal support in acute kidney injury. Finally, we address the implications of the ATN Study results for clinical practice from the perspective of the study investigators.
Palevsky
Paul M
PM
VA Pittsburgh Healthcare System, University Drive, Pittsburgh, PA 15240, USA. Palevsky@pitt.edu
O'Connor
Theresa Z
TZ
Chertow
Glenn M
GM
Crowley
Susan T
ST
Zhang
Jane Hongyuan
JH
Kellum
John A
JA
D058186:Acute Kidney Injury / Q000401:mortality / Q000628:therapy*; D003422:Critical Care; D006801:Humans; D007022:Hypotension / Q000209:etiology; D015337:Multicenter Studies as Topic; D017063:Outcome Assessment, Health Care; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis / Q000379:methods*; D012107:Research Design; D014481:United States / Q000453:epidemiology; D014493:United States Department of Veterans Affairs
JAMA. 2008 Feb 20;299(7):793-805
18285591
Clin J Am Soc Nephrol. 2008 May;3(3):869-75
18235146
N Engl J Med. 2008 Jul 3;359(1):7-20
18492867
Kidney Int Suppl. 2000 Aug;76:S3-18
10936795
N Engl J Med. 2008 Oct 30;359(18):1960-1
18979571
J Crit Care. 2002 Dec;17(4):246-50
12501152
Lancet. 2000 Jul 1;356(9223):26-30
10892761
J Am Soc Nephrol. 2008 Jun;19(6):1233-8
18337480
Perit Dial Int. 1989;9(4):257-60
2488377
Clin Trials. 2005;2(5):423-35
16317811
Kidney Int. 2002 Nov;62(5):1855-63
12371989
N Engl J Med. 2008 Oct 30;359(18):1961; author reply 1961-2
18979572
Nephrol Dial Transplant. 1996 Aug;11(8):1574-81
8856214
Nephrol Dial Transplant. 1998;13 Suppl 6:10-4
9719197
Am J Respir Crit Care Med. 2000 Jul;162(1):197-202
10903241
Adv Ren Replace Ther. 1997 Apr;4(2 Suppl 1):64-71
9113242
Clin J Am Soc Nephrol. 2006 Sep;1(5):915-9
17699307
Kidney Int. 2006 Oct;70(7):1312-7
16850022
Clin J Am Soc Nephrol. 2007 Jul;2(4):623-30
17699474
N Engl J Med. 2008 Oct 30;359(18):1959-60; author reply 1961-2
18979569
Clin J Am Soc Nephrol. 2008 Jul;3(4):955-61
18385390
Crit Care. 2008;12(5):308
18983695
Int J Artif Organs. 2007 Apr;30(4):281-92
17520564
Nephrol Dial Transplant. 2003 May;18(5):961-6
12686672
N Engl J Med. 2008 Oct 30;359(18):1960; author reply 1961-2
18979570
N Engl J Med. 2008 Oct 30;359(18):1959; author reply 1961-2
18971499
Curr Opin Crit Care. 2006 Dec;12(6):551-6
17077685
Crit Care. 2007;11(6):232
18001499
Lancet. 2006 Jul 29;368(9533):379-85
16876666